Drugs Online » Prescription Drugs 16 » Trioptal Trileptal
Oxcarbazepine is an antiepileptic drug. Oxcarbazepine is indicated for use as monotherapy or adjunctive therapy in the treatment of partial seizures in adults and as monotherapy in the treatment of partial seizures in children aged 4 years and above with epilepsy and as adjunctive therapy in children aged 2 years and above with epilepsy.
Buy Trioptal Trileptal and other Prescription Drugs 16 products online
at Medstore.
Buy Online at Medstore - Click Here!

About Trioptal Trileptal:
Product Type: Prescription Drugs 16
Trioptal (Trileptal Generic Oxcarbazepine)
Trioptal (Trileptal Generic Oxcarbazepine)
Trileptal Generic Oxcarbazepine
150mg 100 Tablets 150mg 200(2 x 100) Tablets 150mg 400(4 x 100) Tablets 300mg 100 Tablets 300mg 200(2 x 100) Tablets 300mg 400(4 x 100) Tablets 600mg 100 Tablets 600mg 200(2 x 100) Tablets 600mg 400(4 x 100) Tablets
Trileptal Generic Oxcarbazepine Trioptal

View more
Prescription Drugs 16
Previous Product Next Product
Drugs Online:
From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.


|